Emerging paradigms in molecular imaging of neuroendocrine tumors: From dual-tracer PET to somatostatin receptor antagonists

Diagn Interv Imaging. 2025 Nov;106(11):373-374. doi: 10.1016/j.diii.2025.07.006. Epub 2025 Jul 23.
No abstract available

Keywords: Molecular imaging; Neuroendocrine tumors; Nuclear medicine; Somatostatin receptor imaging; Theranostics.

Publication types

  • Editorial